UNSPSC 51332900: Antipsychotic ergot alkaloids

Antipsychotic drugs made from alkaloids originally isolated from the ergot fungus Claviceps purpurea (Hypocreaceae). They include compounds that are structurally related to ergoline (ERGOLINES) and ergotamine (ERGOTAMINES). Many of the ergot alkaloids act as alpha-adrenergic antagonists.

UNSPSC 51332900 Antipsychotic ergot alkaloids is a Class code, but the recent state and local activity tagged under it does not align with its nominal scope. The single recent opportunity on file—Seminole County, Florida's IFB for naloxone and drug deactivation systems—involves opioid-reversal medication and harm-reduction equipment, not antipsychotic ergot alkaloids. The mismatch suggests either a coding error in the jurisdiction's procurement system or a misalignment between the code descriptor and actual buying patterns. Naloxone procurement by public health and safety agencies is a legitimate state and local activity, but it falls outside the therapeutic category this code nominally describes.

Seminole County's June 2026 IFB sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The bid closed July 26, 2023, required electronic submission through the county's e-Procurement Portal, and included standard compliance requirements (drug-free workplace certification, E-Verify, workers' compensation and general liability insurance). The contract offered a two-year initial term with a one-year renewal option and potential FEMA funding, which triggered additional federal compliance obligations. Without additional recent opportunities under this code, the activity cannot support a reliable characterization of geographic or issuing-body patterns. Firms pursuing naloxone and related public-health procurement should verify the correct UNSPSC classification with target jurisdictions before submitting proposals.